Arena Pharmaceuticals Inc (ARNA) Return on Assets ROA from the fourth quarter of 2021 to fourth quarter of 2019 and for the year 2021, Average High and Low, Fundamental Ratios from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arena Pharmaceuticals Inc   (NASDAQ: ARNA)


Arena Pharmaceuticals Inc 's ROA from the fourth quarter of 2021 to the fourth quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Arena Pharmaceuticals Inc 's ROA in the fourth quarter of 2021?
Arena Pharmaceuticals Inc recorded a cumulative net loss of $-616 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on assets (ROA) of -62.36%.

However, within the Healthcare sector 962 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2021 from 4433 to 5454.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Total Assets Change -34.08 % -29.36 % -19.04 % 146.22 % 1.24 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -616 -583 -484 -423 -405
Return On Assets (TTM) -62.36 % -53.49 % -40.9 % -33.91 % -37.77 %
ARNA's Total Ranking # 5454 # 4433 # 4287 # 4057 # 4444
Total Assets (TTM) in million 785 901 1,085 1,184 1,190
Seq. Total Assets Change -12.91 % -16.93 % -8.37 % -0.56 % -6.68 %
Seq. Net Income Change - - - - -

ARNA's 5 Years Annual ROA >> Back to ARNA Management Effectiveness >> Compare ARNA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 486
Sector # 963
Overall # 5332

Return On Assets Statistics
High Average Low
76.3 %
-8.84 %
-62.36 %
(Mar 31 2019)   (Dec 31 2021)





Financial Statements
Arena Pharmaceuticals Inc 's Assets $ 785 million ARNA's Balance sheet
Arena Pharmaceuticals Inc 's Income $ -156 million Quarterly ARNA's Income Statement
ARNA's Income by Division See ARNA's Income by Division



Annual Return On Assets (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change -49.8 % 127.59 % 102.46 % 100.74 % -34.18 %
Total Assets in million 785 1,563 687 339 169
Y / Y Net Income Change - - - - -
Net Income in million -616 -405 -29 -93 -23
Annual Return On Assets -78.56 % -25.89 % -4.28 % -27.33 % -13.55 %

ARNA's 5 Years Annual ROA >> Back to ARNA Management Effectiveness >> Compare ARNA ROA to its Competitors



More Return On Assets Ratios
ARNA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ARNA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ARNA's Competitors
Subscribers only: Roa for Arena Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for ARNA's Customers

You may also want to know
ARNA's Roi ARNA's Inventory Turnover Ratio ARNA's Growth Rates ARNA's Dividend Comparisons
ARNA's Profitability Ratios ARNA's Asset Turnover Ratio ARNA's Dividend Growth
ARNA's Roe ARNA's Valuation Ratios ARNA's Financial Strength Ratios ARNA's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2021, within Healthcare Sector ROA

Date modified: 2026-09-18T13:11:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.